 Cardiovascular pharmacology adrenergic dopaminergic receptors therapeutic significance congestive heart failure review localization adrenergic- dopaminergic-adrenoceptors cardiovascular system cardiovascular renal changes activation receptors appropriate agonists role alpha- beta-adrenergic agents treatment heart failure recent studies dopamine DA -receptor agonists novel approach therapy congestive heart failure DA-adrenoceptor agonists afterload vasodilation sodium excretion direct activation renal tubules Fenoldopam selective agonist effective heart failure peripheral vasodilation natriuresis diuresis Dopexamine beta agonist efficacy heart failure due ability mild inotropic support reduction afterload Ibopamine prodrug active metabolite epinine compound effective heart failure mechanism reduction afterload Agonists afterload release norepinephrine levels renin-angiotensin-aldosterone system systems active heart failure ibopamine rational approach therapy present review concept pharmacologic intervention adrenergic dopaminergic influence cardiovascular renal systems changes desirable pharmacotherapy congestive heart failure